Development of technology and study of optimized secreted products of stem cells for collaterogenesis

dc.contributor.author	Sultankulov, B.
dc.contributor.author	Mektepbayeva, D.
dc.contributor.author	Zhiyenbay, Y.
dc.contributor.author	Seralin, A.
dc.contributor.author	Alibek, K.
dc.date.accessioned	2015-10-27T06:04:33Z
dc.date.available	2015-10-27T06:04:33Z
dc.date.issued	2014
dc.identifier.isbn	9786018046728
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/507
dc.description.abstract	Cell therapy using stem cells is a promising strategy for the treatment of ischemic diseases, nevertheless low viability of implanted cells, is one of the main problems limiting stem cell therapy. In addition, there is a risk of proliferation of the transformed cells in mesenchymal stem cells carrying properties of cancer stem cells. Using conditioned media from stem cells instead of stem cell themselves avoids the risks that may arise with the direct use of stem cells. Conditioned media from various stem cells contains a different number of cytokines and growth factors, necessary for the natural process of new vessel formation.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	Nazarbayev University	ru_RU
dc.subject	cell	ru_RU
dc.subject	implanted cells	ru_RU
dc.subject	cell therapy	ru_RU
dc.subject	cytokines	ru_RU
dc.subject	polymer	ru_RU
dc.subject	nanoparticles	ru_RU
dc.subject	angiogenesis	ru_RU
dc.subject	tissue	ru_RU
dc.subject	allogeneic transplantations	ru_RU
dc.subject	clinical application	ru_RU
dc.title	Development of technology and study of optimized secreted products of stem cells for collaterogenesis	ru_RU
dc.type	Abstract	ru_RU